Concepedia

Donald L. Durden

DL

80

Publications

5.4K

Citations

41

H-Index

1979

Active since

Affiliations

University of California San Diego(Current)

Emory University

SignalRx Pharmaceuticals (United States)

Children's Hospital of Los Angeles

Rady Children's Hospital-San Diego

Donald L. Durden is an author at University of California San Diego specializing in medicine, cell biology, and cell signaling.

ORCID

Top concepts

Publications per year

1979–2024

80

Publications

80

PTEN Protects p53 from Mdm2 and Sensitizes Cancer Cells to Chemotherapy

Lindsey D. Mayo, Jack E. Dixon, Donald L. Durden et al. · Journal of Biological Chemistry · 2002 · 345 citations · Full text

A Vascular Targeted Pan Phosphoinositide 3-Kinase Inhibitor Prodrug, SF1126, with Antitumor and Antiangiogenic Activity

Joseph R. Garlich, Pradip De, Nandini Dey et al. · Cancer Research · 2008 · 276 citations

PTEN controls tumor-induced angiogenesis

Shenghua Wen, Javor P. Stolarov, Michael P. Myers et al. · Proceedings of the National Academy of Sciences · 2001 · 244 citations · Full text

PTEN and Hypoxia Regulate Tissue Factor Expression and Plasma Coagulation by Glioblastoma

Yuan Rong, Dawn E. Post, Russell O. Pieper et al. · Cancer Research · 2005 · 240 citations · Full text

Plasminogen activator inhibitor-1 promotes angiogenesis by stimulating endothelial cell migration toward fibronectin.

Chiho Isogai, Walter E. Laug, Hiroyuki Shimada et al. · PubMed · 2001 · 182 citations

, , +16

Rows per page

1–5 of 80